Table 2 Clinical outcomes comparison.

From: Electrical pudendal nerve stimulation versus pelvic floor muscle training with transrectal electrical stimulation for post-radical prostatectomy incontinence: a cohort study

Outcomes

Pre-post treatment difference (mean, SD)

linear regression

(OW cohort)

Sensitivity analysis

Model 1 a

Model 2 b

Model 3 c

β(95%CI)

P

value

β(95%CI)

P

value

β(95%CI)

P value

β(95%CI)

P

value

ICIQ-UI SF

 EPNS

9.26 (5.19)

0.00 (Reference)

 

0.00 (Reference)

 

0.00 (Reference)

 

0.00 (Reference)

 

 PFMT + TES

2.43 (5.99)

-4.34

(-6.65 to -2.02)

< 0.001

-6.83

(-8.21 to -5.45)

< 0.001

-4.39

(-6.54 to -2.23)

< 0.001

-3.94

(-6.25 to -1.64)

< 0.001

24-hr pad test urine loss, g

 EPNS

639.22 (383.99)

0.00 (Reference)

 

0.00 (Reference)

 

0.00 (Reference)

 

0.00 (Reference)

 

 PMFT + TES

109.17 (331.60)

-631.26

(-750.81 to -511.70)

< 0.001

-530.05

(-611.74 to -448.36)

< 0.001

-578.08

(-704.77 to -451.39)

< 0.001

-583.44

(-720.16 to -446.73)

< 0.001

IIQ-7

 EPNS

7.45 (5.27)

0.00 (Reference)

 

0.00 (Reference)

 

0.00 (Reference)

 

0.00 (Reference)

 

 PMFT + TES

2.99 (5.65)

-2.86

(-5.14 to -0.58)

0.014

-4.46

(-5.78 to -3.14)

< 0.001

-3.09

(-5.19 to -0.99)

0.004

-2.48

(-4.73 to -0.23)

0.031

  1. CI, confidence interval; EPNS, electrical pudendal nerve stimulation; ICIQ-UI SF, international consultation on incontinence questionnaire-urinary incontinence short form; IIQ-7, incontinence impact questionnaire-7; OW, overlap-weighting; PFMT, pelvic floor muscle training; TES, transrectal electrical stimulation; SD, standard deviation.
  2. aCrude cohort.
  3. bCovariates adjusted included: age; BMI; duration of urinary incontinence; comorbidity; life style; preoperative history of lower urinary tract symptoms; operation methods; adjuvant radiotherapy; medication intervention history; types of urinary incontinence; postoperative PSA level at initial visit; ICIQ-UI SF; 24-hr pad test urine loss; IIQ-7.
  4. cCovariates adjusted included: age; BMI; duration of urinary incontinence; comorbidity; life style; preoperative history of lower urinary tract symptoms; operation methods; adjuvant radiotherapy; medication intervention history; types of urinary incontinence; postoperative PSA level at initial visit; ICIQ-UI SF; 24-hr pad test urine loss; IIQ-7; postoperative lower urinary tract symptoms (urinary frequency; straining; postmicturition dribble; enuresis; nocturia).